Literature DB >> 21339703

NHE-1 and β1 integrin dependent monocyte adhesion and migration after glucose, insulin or PPARγ stimulation.

Zacharoula Zolota1, George Koliakos, Konstantinos Paletas, Martha Kaloyianni.   

Abstract

In the present study the effect of high glucose concentrations, insulin, PPARγ activators (rosiglitazone) and NHE-1 inhibitors (cariporide) in atherosclerosis-related functions of human monocytes was investigated. Monocyte adhesion to laminin-1, collagen type IV and endothelial cells, as well as monocyte migration through the same substrates were studied. Incubation of the monocyte suspension with high glucose concentrations, insulin and rosiglitazone induced all the studied atherosclerosis-related functions of the monocytes. In all these functions the addition of cariporide counteracted the activity of glucose, insulin and rosiglitazone. The use of antigen for β1 integrin also counteracted the activity of the above in monocyte adhesion in all three substrates. The data of the present study suggests that PPARγ activation in monocytes induces atherosclerosis, and that NHE-1 and β1 integrin play an important role in the beginning of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339703      PMCID: PMC3210210          DOI: 10.4161/cam.5.3.14534

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  57 in total

1.  Monocyte adherence to fibronectin: role of CD11/CD18 integrins and relationship to other monocyte functions.

Authors:  C A Owen; E J Campbell; R A Stockley
Journal:  J Leukoc Biol       Date:  1992-04       Impact factor: 4.962

Review 2.  Role of the Na/H exchanger NHE1 in cell migration.

Authors:  C Stock; A Schwab
Journal:  Acta Physiol (Oxf)       Date:  2006 May-Jun       Impact factor: 6.311

3.  (2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors.

Authors:  M Baumgarth; N Beier; R Gericke
Journal:  J Med Chem       Date:  1997-06-20       Impact factor: 7.446

4.  Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter.

Authors:  C Sardet; A Franchi; J Pouysségur
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

5.  Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators.

Authors:  V Pasceri; H D Wu; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

Review 6.  Basement membrane (type IV) collagen.

Authors:  K Kühn
Journal:  Matrix Biol       Date:  1995-02       Impact factor: 11.583

7.  Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.

Authors:  G Ceolotto; A Gallo; M Miola; M Sartori; R Trevisan; S Del Prato; A Semplicini; A Avogaro
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

Review 8.  The sevenfold way of PKC regulation.

Authors:  W S Liu; C A Heckman
Journal:  Cell Signal       Date:  1998-09       Impact factor: 4.315

9.  Stimulation of Na+/H+ antiport and pyruvate kinase activities by high glucose concentration in human erythrocytes.

Authors:  Martha Kaloyianni; Nikos Tsagias; Panagiotis Liakos; Zacharoula Zolota; Euthymios Christophorides; George G Koliakos
Journal:  Mol Cells       Date:  2004-06-30       Impact factor: 5.034

Review 10.  Clinical thiazolidinediones as PPARgamma ligands with the potential for the prevention of cardiovascular disease in diabetes.

Authors:  Stephanie T de Dios; Richard C O'Brien; Peter J Little
Journal:  Curr Diabetes Rev       Date:  2006-05
View more
  2 in total

1.  Soluble TGFBI aggravates the malignancy of cholangiocarcinoma through activation of the ITGB1 dependent PPARγ signalling pathway.

Authors:  Jungwhoi Lee; Jungsul Lee; Woogwang Sim; Jae-Hoon Kim
Journal:  Cell Oncol (Dordr)       Date:  2022-03-31       Impact factor: 6.730

2.  Reduction of endoglin receptor impairs mononuclear cell-migration.

Authors:  Zhenying Han; Sonali Shaligram; Marie E Faughnan; Dewi Clark; Zhengda Sun; Hua Su
Journal:  Explor Med       Date:  2020-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.